All members have the option of attending our various HTC-centric events which include:
Date: Tuesday, November 7, 2023
Time: 2:00pm – 3:00pm ET
TITLE:
Case Studies of Using BeneFix® (Coagulation Factor IX [Recombinant]) in Different Hemophilia B Patient Populations in an Evolving Treatment Landscape – Is There More to the Story?
SPEAKER:

Doris Quon, MD
Medical Director of the Orthopaedic Hemophilia Treatment Center at the Luskin Orthopaedic Institute for Children in Los Angeles, California